Implanet SA (IMPL):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Implanet SA (IMPL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7864
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Implanet SA (Implanet) is a medical device company that designs, manufactures and markets orthopaedic products. The company offers spine, knee and arthroscopy products. Its spine products are used for the treatment of spinal disorders and spinal fusion surgery. Implanet offers resorbable anchors system; ligament anchor; buttons for femoral fixation; resorbable interference screws; posterior fixation; and primary total knee prosthesis products. The company provides complete, simple and reliable implant solutions to all surgeons. It serves across Australia, Belgium, Brazil, Canary Islands, Colombia, Cyprus, England, Germany, Greece, Italy, Iran, Peru, Russia, Saudi Arabia, South Africa, Spain, Switzerland, Tunisia, and others. Implanet is headquartered in Bordeaux, France.

Implanet SA (IMPL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Implanet SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Implanet SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Implanet SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Implanet SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Implanet SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Implanet SA, Medical Equipment, Deal Details 10
Partnerships 10
WishBone Medical Enters into Distribution Agreement with Implanet 10
Implanet Enters into Agreement with L&K Biomed 11
Implanet Enters into Agreement with Aegis Spine 12
Implanet Enters into Agreement with TFS International 13
Equity Offering 14
Implanet Raises USD2 Million in Private Placement of Shares and Warrants 14
Implant Raises USD7.3 Million in Rights Offering of Shares 15
Implanet Raises USD12.7 Million in Rights Offering of Shares 17
Implanet Plans to Issue New Shares 19
Implanet Completes IPO For US$19 Million 20
Debt Offering 21
Implanet Raises USD162.8 Million in Public Offering of Bonds 21
Asset Transactions 22
Global Healthcare Exchange Acquires Beep N Track Solution From Implanet 22
Implanet SA – Key Competitors 23
Implanet SA – Key Employees 24
Implanet SA – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Strategy And Business Planning 26
Jun 05, 2018: IMPLANET announces opening of a United Kingdom sales branch 26
Financial Announcements 27
Jul 11, 2018: IMPLANET: First-half 2018 revenue 27
Jan 23, 2018: IMPLANET: 2017 revenue of €7.8 million 28
Sep 19, 2017: Implanet Announces 2017 First-Half Results 29
Jul 18, 2017: Implanet Announces H1 2017 Revenue 31
Apr 18, 2017: Implanet announces Q1 2017 revenue 32
Jan 16, 2017: Implanet Reports 2016 Sales Growth of +18% to €7.8 Million 33
Corporate Communications 34
Jun 05, 2018: IMPLANET announces opening of a United Kingdom sales branch 34
Product News 35
May 02, 2018: Implanet announces the first peer-reviewed publication of JAZZ results in complex adult spine surgery 35
Sep 26, 2017: Implanet Strengthens JAZZ Intellectual Property Portfolio 36
Other Significant Developments 37
Oct 10, 2017: Implanet: 20% Increase in Revenue In Q3 2017 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Implanet SA, Medical Equipment, Key Facts, 2017 2
Implanet SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Implanet SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Implanet SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Implanet SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Implanet SA, Deals By Market, 2012 to YTD 2018 8
Implanet SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
WishBone Medical Enters into Distribution Agreement with Implanet 10
Implanet Enters into Agreement with L&K Biomed 11
Implanet Enters into Agreement with Aegis Spine 12
Implanet Enters into Agreement with TFS International 13
Implanet Raises USD2 Million in Private Placement of Shares and Warrants 14
Implant Raises USD7.3 Million in Rights Offering of Shares 15
Implanet Raises USD12.7 Million in Rights Offering of Shares 17
Implanet Plans to Issue New Shares 19
Implanet Completes IPO For US$19 Million 20
Implanet Raises USD162.8 Million in Public Offering of Bonds 21
Global Healthcare Exchange Acquires Beep N Track Solution From Implanet 22
Implanet SA, Key Competitors 23
Implanet SA, Key Employees 24
Implanet SA, Subsidiaries 25

List of Figures
Implanet SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Implanet SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Implanet SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Implanet SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Implanet SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Implanet SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Implanet SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Implanet SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Implanet SA (IMPL):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Acorn Energy, Inc. (ACFN):企業の財務・戦略的SWOT分析
    Acorn Energy, Inc. (ACFN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Taoping Inc (CNIT):企業の財務・戦略的SWOT分析
    Summary Taoping Inc (TAOP), formerly China Information Technology Inc, is a cloud-based ad terminal and service provider. The company provides TAOP chain, a system derived from the new media platform that helps online and offline marketing channels. TAOP offers services such as distribution platform …
  • Natrix Separations Inc-製薬・医療分野:企業M&A・提携分析
    Summary Natrix Separations Inc (Natrix), formerly Nysa Membrane Technologies is a medical device company that provides disposable products. The company’s products line comprise HD-Q membrane adsorbers and bind-elute products. Its HD-Q membrane adsorbers finds application in single-use flow-through p …
  • Vocalink Limited
    Vocalink Limited - Strategy, SWOT and Corporate Finance Report Summary Vocalink Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Abg Sundal Collier Holding Asa:企業の戦略・SWOT・財務分析
    Abg Sundal Collier Holding Asa - Strategy, SWOT and Corporate Finance Report Summary Abg Sundal Collier Holding Asa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Shenzhen Moso Power Supply Technology Co Ltd (002660):電力:M&Aディール及び事業提携情報
    Summary Shenzhen Moso Power Supply Technology Co Ltd (Moso Power) is a manufacturer of electronics and electrical appliances. The company designs and distributes consumer electronics and solar photovoltaic products. Its products include LED driver, outdoor lighting, industrial lighting, landscape li …
  • CITIC Securities Company Limited:戦略・SWOT・企業財務分析
    CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report Summary CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Capricor Therapeutics Inc (CAPR):企業の財務・戦略的SWOT分析
    Summary Capricor Therapeutics Inc (Capricor) is a biotechnology company that discovers, develops and commercializes biological therapeutics for the treatment of rare disorders. The company offers cardiac cell therapy and cenderitide products for the treatment of post myocardial infarction, advanced …
  • Viatris Inc (VTRS):企業の財務・戦略的SWOT分析
    Viatris Inc (VTRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • gategroup Holding AG:企業の戦略・SWOT・財務情報
    gategroup Holding AG - Strategy, SWOT and Corporate Finance Report Summary gategroup Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Sfinks Polska S.A.:企業の戦略・SWOT・財務分析
    Sfinks Polska S.A. - Strategy, SWOT and Corporate Finance Report Summary Sfinks Polska S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Genesis Energy LP (GEL):石油・ガス:M&Aディール及び事業提携情報
    Summary Genesis Energy LP (Genesis) is a midstream oil and gas company. The company provides services such as offshore pipeline transportation, refinery services, marine transportation, and onshore facilities and transportation. It purchases, transports, stores, blends, and markets crude oil and ref …
  • SGL Carbon SE (SGL):企業の財務・戦略的SWOT分析
    SGL Carbon SE (SGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Gavis Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Gavis Pharmaceuticals LLC (GAVIS), a subsidiary of Lupin Ltd is a healthcare products provider that develops, markets and distributes tablets and oral solutions. The company offers products such as cetrizine hydrochloride, clobetasol propionate, dexmethylphenidate hydrochloride, dextroamphet …
  • John Wood Group Plc (WG.):企業の財務・戦略的SWOT分析
    John Wood Group Plc (WG.) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Dillard’s Inc:戦略・SWOT・企業財務分析
    Dillard's Inc - Strategy, SWOT and Corporate Finance Report Summary Dillard's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Actelion Ltd:企業の戦略・SWOT・財務分析
    Actelion Ltd - Strategy, SWOT and Corporate Finance Report Summary Actelion Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • ImmunoCellular Therapeutics Ltd (IMUC)-医療機器分野:企業M&A・提携分析
    Summary ImmunoCellular Therapeutics Ltd (IMCU) is a clinical-stage biotechnology company which develops immune-based therapies for the treatment of various cancers. The product pipeline of the company includes active immunotherapies and patented monoclonal antibodies. IMCU’s immunotherapies product …
  • Boyd Gaming Corporation:企業のM&A・事業提携・投資動向
    Boyd Gaming Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Boyd Gaming Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Piramal Glass Ltd:企業の戦略・SWOT・財務情報
    Piramal Glass Ltd - Strategy, SWOT and Corporate Finance Report Summary Piramal Glass Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆